Patent details
EP3227675 Title: ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING MYELODYSPLASTIC SYNDROME
Basic Information
- Publication number:
- EP3227675
- PCT Application Number:
- US2015063595
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP158652131
- PCT Publication Number:
- WO2016090077
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING MYELODYSPLASTIC SYNDROME
- French Title of Invention:
- ANTAGONISTES DE L'ACTIVINE-ACTRII ET LEURS UTILISATIONS POUR LE TRAITEMENT DU SYNDROME MYELODYSPLASIQUE
- German Title of Invention:
- ACTIVIN-ACTRII-ANTAGONISTEN UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON MYELODYSPLASTISCHEM SYNDROM
- SPC Number:
Dates
- Filing date:
- 03/12/2015
- Grant date:
- 15/03/2023
- EP Publication Date:
- 11/10/2017
- PCT Publication Date:
- 09/06/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/03/2023
- EP B1 Publication Date:
- 15/03/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/12/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/03/2023
- Name:
- Acceleron Pharma Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
- Name:
- Celgene Corporation
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Agent
- Name:
- VALIPAT
- From:
- 03/04/2023
- Address:
- Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
- To:
Inventor
1
- Name:
- ROVALDI, Christopher
- Address:
- United States (US)
2
- Name:
- ATTIE, Kenneth M.
- Address:
- United States (US)
3
- Name:
- LAADEM, Abderrahmane
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201462086977 P
- Priority Date:
- 03/12/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201462088478 P
- Priority Date:
- 05/12/2014
- Priority Country:
- United States (US)
3
- Priority Number:
- 201562153872 P
- Priority Date:
- 28/04/2015
- Priority Country:
- United States (US)
4
- Priority Number:
- 201562173782 P
- Priority Date:
- 10/06/2015
- Priority Country:
- United States (US)
5
- Priority Number:
- 201562218728 P
- Priority Date:
- 15/09/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/17; C07K 14/71; G01N 33/49; A61P 7/00; A61P 7/06; A61P 35/02; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202311
- Publication date:
- 15/03/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202315
- Publication date:
- 12/04/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Deed
Power of attorney
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC20230000159A
- Date Registered:
- 03/04/2023
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- VALIPAT
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 28/11/2024
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 03/04/2023 | Request For Change | 2 |
| 03/04/2023 | Outgoing Correspondence | 1 |